Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to content

The SIG focused on the Use of Prefilled Syringes in Intensive Care Units and Operating Theatres (financially supported by BD) works on the development of a value framework using multiple criteria decision analysis to support evidence-based implementation and purchasing. The SIG’s discussions are focusing on both pharmacy-prepared and industry-manufactured prefilled syringes that are filled before they reach the end user.

A PFS is a presentation of one or more active medicines, at the required concentration and volume, in the final syringe and ready for parenteral administration to the patient. PFS are intended to reduce error and minimise the time taken to prepare parenteral medicine by staff in clinical areas. PFS are manufactured/prepared by pharmaceutical industry or hospital pharmacies.

Several additional benefits and some disadvantages have been reported for PFS. The SIG is preparing a comprehensive literature review on PFS.

Usage of PFS in hospitals in North America has been considerably larger than in Europe for many years. Recently the use of PFS in some European countries has increased.

Multi-professional Survey on the Use of Prefilled Syringes in Hospitals

EAHP’s SIG focused on the Use of Prefilled Syringes in Intensive Care Units and Operating Theatres has designed a survey to collect the views and opinions of a range of health professionals and managers on the current and future use of PFS. Participation in this survey assisted the SIG to prepare a report for EAHP and other stakeholders to support the use of PFS in European hospitals. The survey closed on the 31st of August 2022.

Professional Healthcare Associations Survey on the Use of Prefilled Syringes in Hospitals

EAHP’s focused on the Use of Prefilled Syringes in Intensive Care Units and Operating Theatres has also created a survey targeting professional healthcare association to collect their views and opinions on the current and future use of PFS. The SIG looked for one response per individual association. The survey closed on the 31st of August 2022.

×